Nevakar spins off ophthalmic-only company Vyluma

Video

A new ophthalmic-only pharma company was formed when Nevakar spun off its pipeline of ocular drugs.

Navneet Puri, PhD, founder, chairman, and CEO of newly formed Vyluma discusses why Nevakar chose to make the move to ophthalmic-only pharma.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Carolyn Majcher, OD, FAAO, detailed a talk she gave alongside Mary Beth Yackey, OD, at Optometry's Meeting 2025.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
Dr Ashley Tucker Wallace discusses the intersection of pediatric dry eye and myopia control
Related Content
Children on bikes wearing glasses Image credit: SightGlass Vision

DOT lenses for slowing myopia progression worn by a total of 1 million children

Jordana Joy, Associate Editor
August 22nd 2025
Article
You and Eye by Optometry Times with host Miriam Korik, OD

You and Eye: Myopia cannot be viewed as a specialty in today's practice setting

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
August 22nd 2025
Podcast
Pediatric myopia and the urgent need for early intervention - Image credit: ©Kiryakova Anna—stock.adobe.com

Pediatric myopia and the urgent need for early intervention

David L. Kading, OD, FAAO, FCLSA
August 22nd 2025
Article
You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

You and Eye: Mastering myopia management - with Justin Kwan, OD, FAAO

Miriam Korik, OD;Justin Kwan, OD, FAAO;Emily Kaiser Maharjan, Assistant Managing Editor
August 22nd 2025
Podcast
Graphic of stock increase Image credit: AdobeStock/serdon

Myopic macular degeneration market analysis estimates significant growth in the next decade

Jordana Joy, Associate Editor
August 22nd 2025
Article
Santen begins European rollout of low-dose atropine for myopia in Germany - Image credit: ©Christian Müller—stock.adobe.com

Santen begins European rollout of low-dose atropine for myopia in Germany

Emily Kaiser Maharjan, Assistant Managing Editor
August 22nd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.